Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"The Impact of Meropenem Strategy on Treatment Efficacy in Sepsis and Septic Shock : Extended vs. Intermittent Dosing in the ICU"

NCT07398703 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07398703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07398703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"The Impact of Meropenem Strategy on Treatment Efficacy in Sepsis and Septic Shock : Extended vs. Intermittent Dosing in the ICU"
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2027
Completion date
April 30, 2028
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock